TWO SIGMA ADVISERS, LP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$462,336
-74.5%
51,600
-67.9%
0.00%
-80.0%
Q2 2023$1,810,125
-33.6%
160,900
-32.0%
0.01%
-28.6%
Q1 2023$2,724,480
+119.1%
236,500
+120.4%
0.01%
+133.3%
Q4 2022$1,243,607
+144.8%
107,300
+168.2%
0.00%
+200.0%
Q3 2022$508,000
+204.2%
40,000
+64.6%
0.00%
Q2 2022$167,000
-64.3%
24,300
-49.9%
0.00%
-100.0%
Q1 2022$468,000
-21.1%
48,500
-2.8%
0.00%0.0%
Q4 2021$593,000
+33.3%
49,900
+82.1%
0.00%0.0%
Q3 2021$445,000
-18.3%
27,400
+5.8%
0.00%0.0%
Q2 2021$545,000
-3.4%
25,900
-28.7%
0.00%
-50.0%
Q1 2021$564,000
+10.2%
36,300
+48.8%
0.00%
+100.0%
Q4 2020$512,00024,4000.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders